Detalhe da pesquisa
1.
Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab.
Rheumatology (Oxford)
; 61(12): 4905-4909, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266512
2.
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis.
Rheumatology (Oxford)
; 60(8): 3679-3688, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432358
3.
Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis.
Rheumatology (Oxford)
; 59(10): 2838-2846, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065634
4.
Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
Rheumatology (Oxford)
; 56(8): 1348-1357, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444364
5.
An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial.
Ann Rheum Dis
; 74(6): 1195-201, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443001
6.
Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions.
Ann Rheum Dis
; 74(9): 1734-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854586
7.
Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes.
Arthritis Rheumatol
; 76(4): 510-521, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059326
8.
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
Lancet Rheumatol
; 5(2): e88-e98, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712951
9.
Reduced-dose rituximab in rheumatoid arthritis: efficacy depends on degree of B cell depletion.
Arthritis Rheum
; 63(3): 603-8, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21360489
10.
B cell biomarkers of rituximab responses in systemic lupus erythematosus.
Arthritis Rheum
; 63(10): 3038-47, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21618204
11.
Single-centre experience of refractory rheumatoid arthritis.
Rheumatol Adv Pract
; 6(2): rkac057, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35937776
12.
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome.
ACR Open Rheumatol
; 4(8): 689-699, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666029
13.
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.
Front Immunol
; 12: 803175, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35095887
14.
Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab.
Front Med (Lausanne)
; 7: 498, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984378
15.
Response to Dr Bredemeier's letter.
Ann Rheum Dis
; 73(6): e34, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24632007
16.
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol
; 71(11): 1812-1823, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31131994
17.
Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis.
Ann Rheum Dis
; 72(3): 463-4, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23144447
18.
Concomitant cyclophosphamide and oral immunosuppressants with rituximab for systemic lupus erythematosus.
Rheumatology (Oxford)
; 51(6): 1131-2, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491718
19.
Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic.
Lancet Rheumatol
; 2(7): e386-e387, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32835240
20.
Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis.
Arthritis Rheum
; 58(10): 2993-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18821683